| Literature DB >> 33983946 |
Aidil Zaini1,2, Kim L Good-Jacobson1,2, Colby Zaph1,2.
Abstract
The current approaches to reduce the burden of chronic helminth infections in endemic areas are adequate sanitation and periodic administration of deworming drugs. Yet, resistance against some deworming drugs and reinfection can still rapidly occur even after treatment. A vaccine against helminths would be an effective solution at preventing reinfection. However, vaccines against helminth parasites have yet to be successfully developed. While T helper cells and innate lymphoid cells have been established as important components of the protective type 2 response, the roles of B cells and antibodies remain the most controversial. Here, we review the roles of B cells during intestinal helminth infection. We discuss the potential factors that contribute to the context-specific roles for B cells in protection against diverse intestinal helminth parasite species, using evidence from well-defined murine model systems. Understanding the precise roles of B cells during resistance and susceptibility to helminth infection may offer a new perspective of type 2 protective immunity.Entities:
Year: 2021 PMID: 33983946 PMCID: PMC8118336 DOI: 10.1371/journal.pntd.0009340
Source DB: PubMed Journal: PLoS Negl Trop Dis ISSN: 1935-2727
Fig 1A paradigm of Th1/Th2 response during helminth infection.
During a Th2 cell-biased response, epithelial cell-derived cytokines such as TSLP and IL-33, in addition to tuft cell-derived IL-25, collectively result in the activation of type 2 response through Th2 cells and ILC2s. Once activated, these cells produce the type 2 cytokines IL-4, IL-5, and IL13 that in turn activate effector mechanisms for worm expulsion such as goblet cell hyperplasia, increased mucus production (Muc), muscle contractility, and production of RELM-β. In contrast, a Th1-biased response results in susceptibility. Activated IL-12-, IL-18-, and IL-27-induced Th1 cells (under some circumstances) robustly produce IFN-γ, which synergistically represses the type 2 response. IFN-γ, interferon gamma; ILC2, innate lymphoid cell 2; Muc, mucin; RELM-β, resistin-like molecules β; TSLP, thymic stromal lymphopoietin.
Fig 2The protective roles of a GC-Tfh response during helminth infection.
During early stages of helminth infection, DCs in the lamina propria process the parasite-derived antigen, which then migrate to the MLNs. In MLNs, the DCs alongside B cells interact with naive CD4 T cells that result in Th2 and Tfh cell differentiation. In the presence of specific signals, Th2 cells are then localised to the effector sites and are predominantly responsible for the effector type 2-mediated worm expulsion response. On the other hand, Tfh cells interact with activated B cells for the formation of GC reactions in the MLNs. In the DZ, the B cells undergo further proliferation and SHM, resulting in higher affinity of B cell receptors. The B cells then migrate to the LZ and are selected by Tfh cells via specific interactions and Tfh-derived cytokines such as IL-4 and IL-21, to return to the DZ. Such a process occurs in an iterative fashion in order to produce an effective antibody repertoire such as IgG1 and IgE. The GC-Tfh cells can also differentiate into effector Th2 cells and vice versa. The GC-derived B cells can develop into long-lived memory B cells (Image created with Biorender.com). DC, dendritic cell; DZ, dark zone; GC, germinal center; ILC2, innate lymphoid cell 2; LZ, light zone; MLN, mesenteric lymph node; SHM, somatic hypermutation.
Experiments using a passive immunization approach to study the role of antibodies during intestinal helminth infection.
| Helminth species | Outcome | Proposed mechanism | Reference |
|---|---|---|---|
| Transfer of purified IgG1 and IgE induces more than 70% protection against the parasites. | Antibody-mediated reduction of parasite burden | [ | |
| Transfer of purified parasite-specific but not nonspecific IgG1 from resistant mice into mature B cell-deficient mice (μMT−/− mice) significantly reduces worm burden. | [ | ||
| Transfer of human immune serum or purified IgG induces larval killing in implanted diffusion chambers. | [ | ||
| Multiple transfers of parasite-specific IgG derived from immunized mice reduces by at least 64% of larvae burden. | [ | ||
| Transfer of parasite-specific IgG derived from vaccinated mice reduces adult worm burden. | [ | ||
| Transfer of parasite-specific IgG derived from vaccinated mice reduces parasitic egg output. | Antibody-mediated impact on worm fecundity | ||
| Transfer of naive serum or purified IgG into mice lacking a heavy chain joining region in their B cell receptor (JHD−/− mice) reduces parasitic egg output. | [ | ||
| Transfer of immune serum into infected WT mice reduces parasitic egg output. | [ | ||
| Transfer of immune IgA renders protection in a dose-dependent manner. | Antibody-mediated reduction of parasite burden | [ | |
| Transfer of serum from immune, vaccinated mice produces about 54%–63% reduction in larvae 3 in the lungs upon challenge. | [ | ||
| Transfer of immune serum into JHD−/− mice following secondary inoculation attenuates adult worm burden. | [ | ||
| Transfer of parasite-specific serum reduces by at least 95% of muscle larvae development. | [ | ||
| Transfer of immune serum into activation-induced cytidine deaminase-deficient mice (AID−/− mice) restores worm expulsion. | [ | ||
| Transfer of immune serum and eosinophils into eosinophil-deficient mice prevents migratory newborn larvae towards skeletal muscle upon reinfection. | [ | ||
| Transfer of 8F12 monoclonal antibodies targeting the parasite induces 24%–25% reduction in muscle larvae burden. | [ | ||
| Transfer of monoclonal antibodies against the complement C9 binding domain reduces larvae burden upon challenge. | [ |
Experiments using specific mouse models to study the role of antibodies and B cells during intestinal helminth infection.
| Type of B cell/antibody-targeted mouse model | Helminth species | Outcome | Proposed mechanism | Reference |
|---|---|---|---|---|
| Membrane-bound-IgM-deficient mice (μMT−/−) | μMT−/− mice failed to expel adult worms following primary infection. Parasite antigen-restimulated mesenteric lymph node (MLN) cells produced naive levels of Th2 cytokines. | B cells mediate effector Th2 response during primary infection | [ | |
| Vaccinated μMT−/− mice failed to produce degranulated eosinophils and harboured more larvae 3 than control mice. | Antibody-mediated eosinophil response | [ | ||
| Immunized μMT−/− mice exhibited 17% reduction in larvae recovery upon challenge. | B cells mediate larvae expulsion upon recall | [ | ||
| Infection-primed μMT−/− mice harboured higher numbers of adult worms and failed to induce protective germinal center (GC) response and memory Th2 cell response. | GC B cells mediate memory Th2 response | [ | ||
| Vaccinated μMT−/− mice failed to expel adult worms. | B cells mediate worm expulsion upon recall response | [ | ||
| Mice lacking activation-induced cytidine deaminase-deficient (JHD−/−) | JHD−/− mice harboured a higher worm burden upon secondary infection and more motile larvae burden than control. | Antibody-mediated reduction of parasite burden upon recall response | [ | |
| JHD−/− exhibited susceptibility and increased fecal eggs. | B cells mediate worm expulsion | [ | ||
| Activation-induced cytidine deaminase-deficient mice (AID−/−) | AID−/− mice harboured more adult worms upon recall response than control and suffered impaired intestinal repair following primary infection. | Isotype-switched antibody is necessary for worm expulsion upon recall response and regulates intestinal repair | [ | |
| Mice that are unable to secrete any soluble antibodies (IgMi−/−) | IgMi−/− mice exhibited higher numbers of adult worms and exhibited more inflamed intestinal tissue than control. Parasite antigen-restimulated MLN cells failed to produce IL-13. | Antibody-mediated worm expulsion during primary response | [ | |
| IgE-deficient mice (IgE−/−) | IgE−/− mice retain the ability to remain resistant to primary infection. | IgE-independent worm expulsion | [ |